Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Australian American Pharmaceutical Company (AAPC) was a specialty pharmaceutical manufacturer based in West St. Paul, Minnesota, that focused on the development and production of liquid and semi-solid dosage forms. The company specialized in topical generic medications, including creams, ointments, and gels, and served as a contract manufacturing organization (CMO) for the broader pharmaceutical industry. AAPC was acquired by Paddock Laboratories in 2005, which integrated AAPC's manufacturing capabilities and product portfolio into its own operations. Following Paddock's acquisition by Perrigo in 2011 and the subsequent divestiture of Perrigo's generics business, the legacy of AAPC now resides within the Padagis organization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Australian American Pharmaceutical Company.